RBC Bioscience

RBC Bioscience Liabilities

The The Liabilities of RBC Bioscience (6848.TWO) as of Oct 8, 2026 is 514.58 M TWD. In the previous year, The Liabilities was 513.08 M TWD — a change of 0.29% (higher).

Liabilities

514.58 MTWD

YoY

0.29%

Last updated:

In 2024, RBC Bioscience's total liabilities amounted to 514.58 M TWD, a 0.29% difference from the 513.08 M TWD total liabilities in the previous year.

The RBC Bioscience Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
80.71 M TWD
Jan 1, 2019
27.16 M TWD
Jan 1, 2020
337.89 M TWD
Jan 1, 2021
590.77 M TWD
Jan 1, 2022
541.73 M TWD
Jan 1, 2023
513.08 M TWD
Jan 1, 2024
514.58 M TWD
The RBC Bioscience Liabilities history
YEARLiabilitiesYoY
514.58 MTWD+0.29%
513.08 MTWD-5.29%
541.73 MTWD-8.30%
590.77 MTWD+74.84%
337.89 MTWD+1,144.29%
27.16 MTWD-66.35%
80.71 MTWD—
Access this data via the Eulerpool API
Get Free API Key

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing RBC Bioscience's Liabilities

RBC Bioscience's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating RBC Bioscience's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing RBC Bioscience's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

RBC Bioscience's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in RBC Bioscience’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about RBC Bioscience stock

The Liabilities of RBC Bioscience is 514.58 M TWD in 2024.

The Liabilities of RBC Bioscience changed from 513.08 M TWD to 514.58 M TWD, representing a 0.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's RBC Bioscience historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — RBC Bioscience

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — RBC Bioscience